BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

505 related articles for article (PubMed ID: 19076345)

  • 1. Basic and clinical immunology of Siglecs.
    von Gunten S; Bochner BS
    Ann N Y Acad Sci; 2008 Nov; 1143():61-82. PubMed ID: 19076345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The membrane-proximal immunoreceptor tyrosine-based inhibitory motif is critical for the inhibitory signaling mediated by Siglecs-7 and -9, CD33-related Siglecs expressed on human monocytes and NK cells.
    Avril T; Floyd H; Lopez F; Vivier E; Crocker PR
    J Immunol; 2004 Dec; 173(11):6841-9. PubMed ID: 15557178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-affinity ligands of Siglec receptors and their therapeutic potentials.
    Magesh S; Ando H; Tsubata T; Ishida H; Kiso M
    Curr Med Chem; 2011; 18(23):3537-50. PubMed ID: 21756229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cloning, characterization, and phylogenetic analysis of siglec-9, a new member of the CD33-related group of siglecs. Evidence for co-evolution with sialic acid synthesis pathways.
    Angata T; Varki A
    J Biol Chem; 2000 Jul; 275(29):22127-35. PubMed ID: 10801860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD33-related sialic-acid-binding immunoglobulin-like lectins in health and disease.
    McMillan SJ; Crocker PR
    Carbohydr Res; 2008 Aug; 343(12):2050-6. PubMed ID: 18279844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Negative regulation of T cell receptor signaling by Siglec-7 (p70/AIRM) and Siglec-9.
    Ikehara Y; Ikehara SK; Paulson JC
    J Biol Chem; 2004 Oct; 279(41):43117-25. PubMed ID: 15292262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolution of CD33-related siglecs: regulating host immune functions and escaping pathogen exploitation?
    Cao H; Crocker PR
    Immunology; 2011 Jan; 132(1):18-26. PubMed ID: 21070233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Siglecs: sialic-acid-binding immunoglobulin-like lectins in cell-cell interactions and signalling.
    Crocker PR
    Curr Opin Struct Biol; 2002 Oct; 12(5):609-15. PubMed ID: 12464312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Siglecs as targets for therapy in immune-cell-mediated disease.
    O'Reilly MK; Paulson JC
    Trends Pharmacol Sci; 2009 May; 30(5):240-8. PubMed ID: 19359050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Siglecs in the immune system.
    Crocker PR; Varki A
    Immunology; 2001 Jun; 103(2):137-45. PubMed ID: 11412300
    [No Abstract]   [Full Text] [Related]  

  • 11. Recognition of sialylated meningococcal lipopolysaccharide by siglecs expressed on myeloid cells leads to enhanced bacterial uptake.
    Jones C; Virji M; Crocker PR
    Mol Microbiol; 2003 Sep; 49(5):1213-25. PubMed ID: 12940982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cloning and characterization of a novel mouse Siglec, mSiglec-F: differential evolution of the mouse and human (CD33) Siglec-3-related gene clusters.
    Angata T; Hingorani R; Varki NM; Varki A
    J Biol Chem; 2001 Nov; 276(48):45128-36. PubMed ID: 11579105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sialic acid binding receptors (siglecs) expressed by macrophages.
    Munday J; Floyd H; Crocker PR
    J Leukoc Biol; 1999 Nov; 66(5):705-11. PubMed ID: 10577497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Siglecs in Brain Function and Neurological Disorders.
    Siddiqui SS; Matar R; Merheb M; Hodeify R; Vazhappilly CG; Marton J; Shamsuddin SA; Al Zouabi H
    Cells; 2019 Sep; 8(10):. PubMed ID: 31546700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of CD33-related siglecs on human mononuclear phagocytes, monocyte-derived dendritic cells and plasmacytoid dendritic cells.
    Lock K; Zhang J; Lu J; Lee SH; Crocker PR
    Immunobiology; 2004; 209(1-2):199-207. PubMed ID: 15481154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Siglecs, sialic acids and innate immunity.
    Crocker PR; Varki A
    Trends Immunol; 2001 Jun; 22(6):337-42. PubMed ID: 11377294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural ligands for CD33-related Siglecs?
    Varki A
    Glycobiology; 2009 Aug; 19(8):810-2. PubMed ID: 19429924
    [No Abstract]   [Full Text] [Related]  

  • 18. New I-type lectins of the CD 33-related siglec subgroup identified through genomics.
    Crocker PR; Zhang J
    Biochem Soc Symp; 2002; (69):83-94. PubMed ID: 12655776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new siglec family member, siglec-10, is expressed in cells of the immune system and has signaling properties similar to CD33.
    Whitney G; Wang S; Chang H; Cheng KY; Lu P; Zhou XD; Yang WP; McKinnon M; Longphre M
    Eur J Biochem; 2001 Dec; 268(23):6083-96. PubMed ID: 11733002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probing sialic acid binding Ig-like lectins (siglecs) with sulfated oligosaccharides.
    Rapoport EM; Pazynina GV; Sablina MA; Crocker PR; Bovin NV
    Biochemistry (Mosc); 2006 May; 71(5):496-504. PubMed ID: 16732727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.